Related Experiment Video
Updated: Aug 9, 2026
09:07
Murine Model of Epicutaneously-Induced Immunomodulation
Published on: June 24, 2025
[Effect of taurochenodeoxycholic acid on immune function in mice]
Xiuling He1, Peifeng Li, Hong Guan
1Inner Mongolia Agricultural University, Huhehaote.
Summary
Taurochenodeoxycholic acid (TCDCA) enhances immune function in mice by boosting lymphocytes and phagocytosis. This bile acid also inhibits delayed type hypersensitivity, indicating a significant immunomodulatory effect.
Area of Science:
- Immunology
- Biochemistry
Context:
- The immune system's complex functions are critical for maintaining health.
- Bile acids, such as Taurochenodeoxycholic Acid (TCDCA), are increasingly recognized for roles beyond digestion.
- Understanding TCDCA's immunomodulatory potential is crucial for exploring novel therapeutic strategies.
Purpose:
- To investigate the specific effects of Taurochenodeoxycholic Acid (TCDCA) on various aspects of immune function in a murine model.
Summary:
- TCDCA administration significantly increased the proportion of CD4+ and CD19+ lymphocytes and the CD4+/CD8+ ratio in peripheral blood.
- The study observed enhanced serum hemolysin and lysozyme levels, indicating improved humoral immunity.
- TCDCA markedly improved the phagocytic capacity of the mononuclear phagocyte system and notably inhibited delayed type hypersensitivity responses.
Impact:
- These findings demonstrate that TCDCA possesses significant immunomodulatory properties.
- TCDCA enhances both cellular and humoral immune responses in mice.
- The immunopotentiating effects of TCDCA suggest its potential as a therapeutic agent for immune dysfunction.